Despite the demonstration of the strong association between HLA-B27 and ankylosing spondylitis (AS)"1 2 the mechanism which links them is obscure.
The lack of disease concordance among B27+ identical twins3 and the observation that only a subpopulation of B27+ individuals acquires AS argue strongly for an environmental factor which triggers the disease in susceptible individuals. The demonstration that individuals with AS shed Klebsiella pneumoniae in their faeces more frequently than normal B27+ individuals4 suggests that infection with this organism may predispose certain individuals to spondylarthropathy. In support of this, an increase in the frequency of faecal isolation of klebsiella species during disease activity (as compared with quiescent disease) has been demonstrated.' Geczy and his coworkers first showed, using a 5tCr release assay, that sera raised in rabbits against certain subtypes of K. pneumoniae will specifically lyse AS+B27+ peripheral blood lymphocytes (PBLs), but not B27+ PBLs from healthy individuals. Furthermore, the cells from healthy AS-B27+ individuals became susceptible to Accepted for publication 7 August 1984. Correspondence to Dr J A Trapani. lysis by the same antisera after incubation with a cell-free culture filtrate derived from such strains of klebsiella.7 Thus the cell surface of healthy B27+ cells becomes 'modified' after contact with klebsiella products. The ability of B27+ PBLs from normal subjects (but not B27+ PBLs from subjects with AS) to absorb this 'modifying activity' from klebsiella supernatants strongly suggests the presence of a soluble factor released from klebsiella which is able to adhere to a receptor on B27+ cells and initiate cellular changes which are somehow involved in the induction of AS. This is an attractive hypothesis and provides a direct link between the disease, the organism, and the HLA-B27 antigen. Initial characterisation of this soluble factor by means of Biogel P100 chromatography suggested it to be a glycoprotein of 26-3OKd,8 and more recently it has been shown that the ability to produce this modifying factor is transmissible to other organisms by a plasmid, in that Escherichia coli which take up this plasmid subsequently become able to modify B27+ Radiolabelling. Equal amounts of purified K21 and F77 klebsiella supernatants were radiolabelled with 1251 by the chloramine T method and specific radioactivity calculated at approximately 1-0 Ci/,ug (> 80% trichloracetic acid precipitable counts). Iodinated products were used immediately. Supernatant proteins were biosynthetically labelled by adding 2*5 mCi 3H-leucine to klebsiella cultures overnight. Filtered, biosynthetically labelled material was purified as described above.
Radioactive binding assays. PBLs (2*5x 106) were incubated with radioiodinated or biosynthetically labelled material (5 x 105 cpm) at 37°C for 0-20 hours. Cells were harvested, washed with phosphate buffered saline containing 0-5% (w/v) bovine serum albumin, and the bound radioactivity was detected in a gamma or scintillation counter. All assays were performed in triplicate.
Sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDS-PAGE) analysis. Following osmotic lysis of cells and removal of nuclear material, radiolabelled species bound to B27+ and B27-cells were resuspended in buffer containing 20 mM dithiothreitol and analysed in 12-5% onedimensional Laemmli slab gels. '5 Results The aim of this study was three-fold: firstly, to demonstrate that the klebsiella organisms used and their products were identical to those used in previous studies; secondly, to determine whether klebsiella products bind to HLA-B27+ cells via any of the epitopes defined by anti-HLA-B27 monoclonal antibodies, and, thirdly, to demonstrate either in a quantitative and/or a qualitative fashion, a difference in binding of K21 or K43 klebsiella products to HLA-B27+ and B27-PBLs.
1. Characterisation of klebsiella isolates. The isolates of klebsiella K21, K43, and F77 were subcultured directly from organisms previously extensively characterised.9 (a) Antibiotic sensitivity of klebsiella isolate.-To ensure that the klebsiella organisms used had not altered or lost plasmids during culture, antibiotic sensitivities were determined before and after each experiment and were found to be identical, in each case, to those previously published9 (Table 1) .
(b) Absorbance profiles of F77 and K21 K. pneumoniae supernatants following Fractogel chromatography.-The absorbance profiles (280 nm) for K21 and F77 coincided with each other and with the previously published absorbance data for these klebsiellaet5 (Fig. 1) . Molecules of 50 Kd and 18 Kd were collected at elution volumes of 106 and 118 ml respectively.
2. Blocking of anti-HLA-B27 monoclonal antibody binding. Although klebsiella factor has been shown to be bound only by normal B27+ (but not Log10 antibody dilution (Fig. 2a and 2b) Fig. 3 a, b) (Fig. 4) . Thus, we are unable to demonstrate by quantitative means, the specific binding of a factor derived from klebsiella supernatant to healthy HLA-B27+ PBLs.
We also attempted to demonstrate a qualitative difference in the 18-50 Kd products bound to B27+ and B27-PBLs by analysing bound radiolabelled molecules with one-dimensional SDS-PAGE (Fig.  5) . As expected following Fractogel chromatography, the principal molecules bound from both K21 and F77 klebsiellae fall within a confined range of apparent molecular weights (approx 25-60 Kd) and there is a similarity of the molecular weights of molecules bound from the K21 and F77 isolates. We were unable to identify molecules which either specifically bind to or are absent from B27+ cells. In particular, no molecule of apparent molecular weight of approximately 46 Kd, the previously reported apparent molecular weight of klebsiella factor on polyacrylamide gels,'4 was found to be exclusively present in the tracks of labelled protein from B27+ cells.
Discussion
The finding that certain klebsiella subtypes produce a factor which can bind to B27+ cells from ASindividuals, but not to B27+AS+ cells has generated great interest, as this could provide a link between the bacterium and the disease. Furthermore The study is the first to use specific monoclonal antibodies to determine whether some of the epitopes on the B27 molecule act as binding sites for klebsiella products. Indeed previous studies have produced no strong evidence that the B27 molecule (as opposed to some other molecule, possibly the product of a gene linked to HLA-B27), is the putative receptor. Since at least four HLA-B27 related epitopes have been defined by murine monoclonal antibodies (and others may exist), our study does not exclude these other determinants as binding sites. However, our study has utilised the only two monoclonal antibodies which define epitopes known not to occur on a variety of HLA-B27-cells. 12 Thus, if the determinants defied by B27ml17 and ME1l8 (the two anti-HLA-B27 monoclonals not used in this study) were sites of attachment for klebsiella products, a substantial number of B27-cells should absorb klebsiella modifying factor. This has been shown not to be the case. 6 The inability of B27+ PBLs from AS patients to absorb modifying factor would suggest a polymorphism in the structure of the HLA-B27 molecule if B27 itself were the binding site. However, such a polymorphism has not been detected in two studies using two-dimensional PAGE and tryptic and chymotryptic peptide mapping.19 20 In fact no difference in structure of B27 was noted between subjects with AS and normal subjects. The 
